3 S&P 500 Dividend Stocks with High Yields on Sale: Buy Now and Hold for Long-Term Growth

As an investor, it’s important to keep an eye on the market and identify opportunities for potential growth. While the S&P 500 has seen a remarkable 25% increase over the past year, not every stock has partaken in this rally. In fact, several healthcare stocks have actually fallen more than 25% from their recent peaks.

Despite the drop in stock prices, some high-yield stocks like Pfizer (NYSE: PFE), Bristol Myers Squibb (NYSE: BMY), and CVS Health (NYSE: CVS) still have strong dividend programs that investors can rely on for consistent payouts. These companies have a history of increasing their dividends annually and show promising signs for the future.

Related:  US Dollar (DXY) Index Update: Economic Slowdown and Lower Treasury Yields Impacting CurrencyStrength

1. Pfizer:

Pfizer has seen its shares fall by about 31% in the past year, mainly due to declining sales of its COVID vaccine and antiviral treatment. However, the pharmaceutical giant has been steadily increasing its dividend payout since 2009. With a current yield of 6.1%, Pfizer is expected to continue raising its dividends for at least another decade. The company has a robust pipeline of new drugs and is well-positioned for growth in the coming years.

2. Bristol Myers Squibb:

Bristol Myers Squibb’s stock has dropped by 35% from its peak last year, primarily due to a recent earnings adjustment and a significant acquisition. However, the company’s acquisition of Karuna Therapeutics could be a game-changer, with the potential for a new schizophrenia drug approval by the FDA. At a yield of 5.7%, Bristol Myers Squibb offers compelling opportunities for long-term investors.

Related:  Is Cava the New Chipotle? Revenue Surges, Stock Worth a Buy?

3. CVS Health:

CVS Health, known for its retail pharmacies and healthcare businesses, has seen its stock decline by 27% in recent months. Despite this, the company has a track record of rapidly increasing its dividend payout. With a yield of 4.4%, CVS Health is poised to benefit from the growing healthcare industry and could provide substantial dividend raises over the next decade.

In conclusion, while these high-yield stocks may have experienced setbacks in the short term, they offer attractive opportunities for investors looking to hold for the long term. With strong dividend programs and growth potential, Pfizer, Bristol Myers Squibb, and CVS Health are worth considering for a well-rounded investment portfolio. Stay tuned for more investment insights and opportunities from Extreme Investor Network.